The rising prevalence in GLP-1 agonists for diabetes has generated a question about formats: transdermal systems versus tablets . Traditionally , GLP-1 treatments were solely available in oral form, but the development of skin applications offers a different option . Transdermal systems might benefit individuals with difficulty with oral medicat… Read More